Published in J Med Genet on December 01, 1970
Agammaglobulinemia. Pediatrics (1952) 10.18
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
BETA-2A AGLOBULINEMIA IN TWO HEALTHY MEN. J Lab Clin Med (1964) 2.72
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
[HEREDITARY THYMIC HYPOPLASIA: ITS PLACE AND RESPONSIBILITY IN A CASE OF LYMPHOCYTIC, NORMOPLASMOCYTIC AND NORMOGLOBULINEMIC APLASIA IN AN INFANT]. Arch Fr Pediatr (1964) 2.48
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Studies on the serum gamma-A-globulin level. 3. The frequency of A-gamma-A-globulinemia. Scand J Clin Lab Invest (1965) 2.39
XX-XY lymphoid chimaerism in congenital immunological deficiency syndrome with thymic alymphoplasia. Lancet (1965) 1.99
Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet (1969) 1.92
Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J (1967) 1.88
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Impaired leucotactic responsiveness in a child with recurrent infections. Lancet (1969) 1.78
Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol (1968) 1.70
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med (1965) 1.46
FAMILIAL LYMPHOPENIA WITH AGAMMAGLOBULINEMIA: AN ATTEMPT AT TREATMENT BY IMPLANTATION OF FETAL THYMUS. Lancet (1965) 1.43
[Essential lymphocytophthisis; new clinical aspect of infant pathology]. Ann Paediatr (1950) 1.40
Alymphocytosis, agammaglobulinaemia, homografts, and delayed hypersen sitivity: study of a case. Lancet (1962) 1.26
Antibody deficiency syndrome: a case with normal immunoglobulin levels. Clin Exp Immunol (1968) 1.22
Synthesis of donor type gamma-G-globulin following thymus transplantation in hypo-gamma-globulinaemia with severe lymphocytopenia. Scand J Haematol (1966) 1.20
The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood. J Clin Invest (1968) 1.19
Hereditary lymphopenic agammaglobulinemia associated with a distinctive form of short-limbed dwarfism and ectodermal dysplasia. J Pediatr (1969) 1.17
Carcinogen-induced tumors of the thymus. 3. Restoration of neonatally thymectomized mice with thymomas in cell-impermeable chambers. J Natl Cancer Inst (1969) 1.14
Thymic dysplasia. A separable entity from "swiss agammaglobulinemia". Am J Med Sci (1967) 1.11
Genetic aspects of autoimmunity. Prog Med Genet (1969) 1.03
Thymic alymphoplasia with XX-XY lymphoid chimerism secondary to probable maternal-fetal transfusion. J Pediatr (1969) 1.03
[The Swiss type of agammaglobulinemia]. Ergeb Inn Med Kinderheilkd (1968) 0.96
Immunological profile in a chromosome 18 deletion syndrome with IgA deficiency. J Med Genet (1969) 0.91
Cytogenetic studies in the malignant lymphomas. Lancet (1966) 0.90
Leucocyte abnormality in both parents of a patient with chronic granulomatous disease. Lancet (1969) 0.89
Cytogenetic evidence concerning possible transplacental transfer of leukocytes in pregnant women. Am J Obstet Gynecol (1966) 0.88
A case of Swiss-type agammaglobulinaemia and achondroplasia. Br Med J (1966) 0.85
Graft-vs-host reaction following a single blood transfusion. JAMA (1967) 0.80
Chromosome abnormalities in the malignant lymphomas. Eur J Cancer (1968) 0.77
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Five-year analysis of protective isolation. Lancet (1971) 2.31
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child (1972) 1.93
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol (1996) 1.89
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms. J Urol (1997) 1.40
L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J (1970) 1.39
Recovery of human foetal liver cells after storage in liquid nitrogen. J Clin Pathol (1968) 1.34
Risk factors for acute graft-versus-host disease. Br J Haematol (1987) 1.33
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Further observations on patients with a chromosomal abnormality associated with polycythaemia vera. Br J Haematol (1968) 1.18
Hereditary lymphopenic agammaglobulinemia associated with a distinctive form of short-limbed dwarfism and ectodermal dysplasia. J Pediatr (1969) 1.17
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
Response of human foetal thymocytes to phytohaemagglutinin (PHA). Immunology (1970) 1.14
Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy. Br J Haematol (1976) 1.10
Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet (1970) 1.08
Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.05
Immunological restitution in lymphopenic immunological deficiency syndrome. Lancet (1968) 1.05
Thymic alymphoplasia with XX-XY lymphoid chimerism secondary to probable maternal-fetal transfusion. J Pediatr (1969) 1.03
Agglutination of platelets by a serum factor in the presence of EDTA. J Clin Pathol (1969) 1.03
Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation. Br J Cancer (1977) 1.03
Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer (1978) 1.02
Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases. Br J Haematol (1980) 1.01
Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia. Br Med J (1974) 1.01
Isolated testicular relapse in acute lymphoblastic leukaemia of childhood. Report on behalf of the Medical Research Council's working party on leukaemia in childhood. Arch Dis Child (1983) 1.01
Severe neurological damage associated with methotrexate therapy. Lancet (1971) 1.00
Design and use of plastic tents for isolation of patients prone to infection. Lancet (1968) 1.00
The chromosomes in polycythaemia vera. Br J Haematol (1966) 0.99
Acid-phosphatase reaction in acute lymphoblastic leukaemia. Lancet (1978) 0.99
Analysis of treatment in childhood leukaemia. III. Independence of lymphopenia induced by irradiation and by chemotherapy. Br J Haematol (1977) 0.94
The thymus in immune deficiency. Proc R Soc Med (1968) 0.94
Testicular infiltration in acute lymphoblastic leukaemia. Br J Haematol (1983) 0.93
Lymphocyte transformation in patients with acute lymphoblastic leukaemia. Br Med J (1971) 0.92
Meningeal leukemia after blastic transformation of chronic myeloid leukemia. Cancer (1975) 0.91
Planning and comparisons in clinical trials. Br J Cancer (1983) 0.90
Further cytogenetical investigations in polycythaemia vera. Eur J Cancer (1970) 0.89
The effect of colony age on PCR fingerprinting. Lett Appl Microbiol (1993) 0.89
Busulphan and bone marrow depression. Br Med J (1969) 0.89
Immunoglobulin prophylaxis of measles in acute lymphoblastic leukaemia. Lancet (1984) 0.86
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA (1983) 0.86
Some practical aspects of intensive cytotoxic therapy. Lancet (1967) 0.86
Bone-marrow transplantation for acute leukaemia in first remission. Lancet (1982) 0.86
Thinking the unthinkable at Easingwold. Lancet (1984) 0.85
Fever in the neutropenic patient. Br Med J (1974) 0.85
The Ommaya reservoir in chemotherapy for malignant disease in the CNS. Clin Oncol (1981) 0.84
Studies of parents of children with acute leukemia. J Natl Cancer Inst (1975) 0.83
Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia. Br J Urol (1997) 0.82
Chromosomes of human fetal lymphocytes: frequency of abnormalities and absence of maternal cells. Lancet (1971) 0.82
Adult acute leukaemia. Br J Cancer (1974) 0.82
Early deaths in acute myelogenous leukemia. Cancer (1977) 0.82
The thymus in immune deficiency. Proc R Soc Med (1970) 0.81
Grafting of fetal thymus and hematopoietic tissue in infants with immune deficiency syndromes. Transplantation (1973) 0.81
Letter: Classification of non-Hodgkin's lymphomas. Lancet (1974) 0.81
Development of CNS leukaemia in acute myeloid leukaemia in childhood. Arch Dis Child (1976) 0.80
Cost of bone-marrow transplants in acute myeloid leukaemia. Lancet (1980) 0.80
Major bone lesions in acute lymphoblastic leukaemia. Med Pediatr Oncol (1982) 0.78
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet (1982) 0.78
Surface characteristics of lymphoma cells in relation to treatment, response and survival. Eur J Cancer (1978) 0.76
Immunosuppression and the risk of brain lymphoma. N Engl J Med (1983) 0.76
The International Continence Society "Benign Prostatic Hyperplasia" Study: international differences in lower urinary tract symptoms and related bother. J Urol (1997) 0.76
States of immune deficiency. Rev Eur Etud Clin Biol (1970) 0.76
Molecular evidence for shifts in polysaccharide composition associated with adaptation of soybean Bradyrhizobium strains to the Brazilian Cerrado soils. Environ Microbiol (1999) 0.75
Prevention of cross-infection. Br Med J (1977) 0.75
Septicaemia in the neutropenic patient. Br Med J (1974) 0.75
Two populations of Rh groups together with chromosomally abnormal cell lines in the bone marrow. Br Med J (1971) 0.75
Bone marrow transplantation: 1982. Br Med J (Clin Res Ed) (1982) 0.75
Chromosome banding studies in acute leukaemia at diagnosis. Scand J Haematol (1975) 0.75
The complications of bone marrow suppression. Proc R Soc Med (1970) 0.75
Marrow dysplasia with C trisomy and anomalies of the granulocyte nuclei. J Clin Pathol (1966) 0.75
Infection of immunosuppressed patients. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.75
The control of leucopoiesis. Proc R Soc Med (1967) 0.75
Myelosuppression complicating cotrimoxazole prophylaxis after bone marrow transplantation. Br J Haematol (1984) 0.75
Chromosomes in polycythaemia vera. Br J Haematol (1969) 0.75
Infection and second-remission rates in patients having immunotherapy for acute myeloid keukemia. Lancet (1977) 0.75
Functional disorders of the lymphoreticular system. J Clin Pathol (1972) 0.75
Lymphocyte function. Br J Haematol (1971) 0.75
Acute myeloid leukaemia: comparison of support required during initial induction of remission and marrow transplantation in first remission. Lancet (1981) 0.75
Cyclosporin A in human bone marrow grafts. Haematol Blood Transfus (1980) 0.75
Preparation and uses of platelet concentrates. Br J Haematol (1969) 0.75
Letter: Danger of varicella to immunosuppressed patients. Lancet (1974) 0.75
Transplanting the thymus. Lancet (1969) 0.75
Bone marrow transplantation. Br J Haematol (1976) 0.75
Extramedullary leukaemia. Prog Clin Biol Res (1983) 0.75
Some aspects of current therapy in acute leukemia. Lancet (1967) 0.75
In praise of eponyms. Lancet (1973) 0.75
Zoster immune globulin for immunosuppressed children. Lancet (1980) 0.75
Leukaemia in childhood. Nurs Mirror (1977) 0.75
Infections after bone marrow transplantation using cyclosporine. Transplantation (1983) 0.75
Bone marrow transplantation for acute myelogenous leukaemia. Lancet (1983) 0.75
Bone-marrow transplantation in leukaemia remission. Lancet (1982) 0.75